Virpax Pharmaceuticals, Inc. (VRPX) Ownership
VRPX ownership summary
as of October 21, 2026- Institutions
- 0.0% of shares outstanding
- Insiders
- 0.00% of shares outstanding
- Shares outstanding
- 1.2M
- Float
- 1.1M shares available to trade
- Short interest
- 25.74% 577K shares short
- Days to cover
- 0.59 short interest down 39.6% vs prior month
- Insiders 0.00%
- Other investors 100.00%
VRPX top institutional holders
13 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Geode Capital Management, LLC | 0.13% | 42K | $34 | +13,928 (+49.8%) | December 31, 2024 |
| 2 | HRT FINANCIAL LLC | 0.08% | 25K | $20 | +25,368 (0.0%) | December 31, 2024 |
| 3 | Virtu Financial LLC | 0.07% | 24K | $19 | +23,657 (0.0%) | December 31, 2024 |
| 4 | UBS Group AG | 0.04% | 13K | $10 | −7,335 (−35.9%) | December 31, 2024 |
| 5 | XTX Topco Ltd | 0.04% | 13K | $10 | +12,905 (0.0%) | December 31, 2024 |
| 6 | Tower Research Capital LLC | 0.02% | 7,754 | $6 | +3,917 (+102.1%) | December 31, 2024 |
| 7 | Morgan Stanley - Brokerage Accounts | <0.01% | 499 | $0 | +484 (+3,226.7%) | December 31, 2024 |
| 8 | SBI Securities Co Ltd | 0.01% | 108 | $0 | +84 (+350.0%) | March 31, 2025 |
| 9 | Bank of America Corp | <0.01% | 65 | $0 | +28 (+75.7%) | December 31, 2024 |
| 10 | Hantz Financial Services, INC. | 0.00% | 10 | $0 | — | December 31, 2024 |
| 11 | Citadel Advisors Llc | 0.00% | — | — | −31,382 (−100.0%) | December 31, 2024 |
| 12 | Signature Resources Capital Management, LLC | 0.00% | — | — | −50 (−100.0%) | December 31, 2024 |
| 13 | TWO SIGMA SECURITIES, LLC | 0.00% | — | — | −12,522 (−100.0%) | December 31, 2024 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 13, 8 holders added 80K shares and 4 cut 51K.
VRPX top mutual fund and ETF holders
13 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.08% | 1,012 | $1 | — | March 31, 2025 |
| 2 | Fidelity Series Total Market Index | 0.04% | 503 | $0 | +229 (+83.6%) | March 31, 2025 |
| 3 | Fidelity Total Market Index | 0.03% | 350 | $0 | — | March 31, 2025 |
| 4 | Vanguard Institutional Extnd Mkt Idx Tr | 0.02% | 265 | $0 | — | March 31, 2025 |
| 5 | NT Ext Eq Mkt Indx Fd DC Lend T4 | <0.01% | 137 | $0 | +137 (0.0%) | December 31, 2024 |
| 6 | NT Ext Eq Mkt Indx Fd DC Lend T3 | <0.01% | 137 | $0 | +137 (0.0%) | December 31, 2024 |
| 7 | NT Ext Equity Mkt Idx Fd - NL | <0.01% | 38 | $0 | — | March 31, 2025 |
| 8 | NT Ext Equity Mkt Idx Fd - DC - NL - T2 | <0.01% | 30 | $0 | −1 (−3.2%) | March 31, 2025 |
| 9 | Northern Trust Extended Eq Market Idx | <0.01% | 23 | $0 | — | March 31, 2025 |
| 10 | NT Ext Equity Mkt Idx Fd - L | <0.01% | 23 | $0 | — | March 31, 2025 |
| 11 | Spartan Total Market Index Pool E | <0.01% | 12 | $0 | −1 (−7.7%) | March 31, 2025 |
| 12 | NT Ext Eq Mkt Indx Fd DC Lending Tier 5 | <0.01% | 6 | $0 | — | March 31, 2025 |
| 13 | SSgA U.S. Total Market Index Strategy | <0.01% | 1 | $0 | — | March 31, 2025 |
Funds report holdings monthly or quarterly; dates differ by fund.
VRPX insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2022-05-24 | Jerrold Sendrow | Buy | $322.50 | 18 | $5,805 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
VRPX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns VRPX
Institutional investors own 0.0% of Virpax Pharmaceuticals's shares and insiders 0.00%. The largest holder is Geode Capital Management, LLC with 0.13% of the shares (42K), as of December 31, 2024. Among the top 13 institutions, 8 added shares and 4 reduced their stake in the latest filings. Short interest is 25.74% of the float, or 0.59 days of average trading volume. The share count fell 14.0% since 2019.
Related: VRPX analyst forecast, VRPX key metrics. See the VRPX stock overview for the latest quote and news.
VRPX ownership FAQ
Who owns the most Virpax Pharmaceuticals stock?
The largest shareholders of Virpax Pharmaceuticals are Geode Capital Management, LLC (0.13%), HRT FINANCIAL LLC (0.08%), Virtu Financial LLC (0.07%), UBS Group AG (0.04%), XTX Topco Ltd (0.04%).
What percentage of Virpax Pharmaceuticals is owned by institutions?
Institutions hold 0.0% of Virpax Pharmaceuticals's shares outstanding; insiders hold 0.00%.
Which funds own Virpax Pharmaceuticals?
The largest fund holders of Virpax Pharmaceuticals are Fidelity Extended Market Index (0.08%), Fidelity Series Total Market Index (0.04%), Fidelity Total Market Index (0.03%), Vanguard Institutional Extnd Mkt Idx Tr (0.02%), NT Ext Eq Mkt Indx Fd DC Lend T4 (<0.01%).
What is Virpax Pharmaceuticals's short interest?
577K shares of Virpax Pharmaceuticals were sold short, 25.74% of the float; at the average daily volume it would take 0.59 days to cover.
Are insiders buying or selling Virpax Pharmaceuticals?
Of the latest 1 reported insider transactions in Virpax Pharmaceuticals (since May 24, 2022), 1 were purchases and 0 were sales.
How many shares of Virpax Pharmaceuticals are outstanding?
Virpax Pharmaceuticals has 1.2M shares outstanding, of which 1.1M are in the public float.